Manuela Rabaglio
- Oncology top 2%
- Cancer Research top 2%
- Genetics top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Co-authors
- Alan S. CoatesAron GoldhirschRichard D. GelberKaren N. PriceBeat ThürlimannMarco ColleoniJohn ForbesIan Smith
- Topics
- Estrogen and related hormone effects (28 papers)Breast Cancer Treatment Studies (24 papers)BRCA gene mutations in cancer (14 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Manuela Rabaglio
76 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 96
- Oncology 1.2k
- Cancer Research 819
- Genetics 779
- Pulmonary and Respiratory Medicine 589
- Molecular Biology 298
Countries citing papers authored by Manuela Rabaglio
This map shows the geographic impact of Manuela Rabaglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Rabaglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Rabaglio more than expected).
Fields of papers citing papers by Manuela Rabaglio
This network shows the impact of papers produced by Manuela Rabaglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Rabaglio. The network helps show where Manuela Rabaglio may publish in the future.
Co-authorship network of co-authors of Manuela Rabaglio
This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Rabaglio. A scholar is included among the top collaborators of Manuela Rabaglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Rabaglio. Manuela Rabaglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 2 | |
| 7 | 12 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 8 | |
| 12 | 8 | |
| 13 | 107 | |
| 14 | Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014) | 5 |
| 15 | 33 | |
| 16 | 102 | |
| 17 | 46 | |
| 18 | 133 | |
| 19 | 93 | |
| 20 | 106 |
About Manuela Rabaglio
Manuela Rabaglio is a scholar working on Cancer Research, Genetics and Oncology, having authored 83 papers that have together received 2.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (28 papers), Breast Cancer Treatment Studies (24 papers) and BRCA gene mutations in cancer (14 papers). The work is most often cited by research in Cancer Research (819 citations), Oncology (1.2k citations) and Family Practice (72 citations). Manuela Rabaglio has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, Karen N. Price, Beat Thürlimann, Marco Colleoni, John Forbes, Ian Smith, Meredith M. Regan and Bent Ejlertsen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.